sproggle
Jan
- Messages
- 235
- Location
- Teesside, England UK
New total for UK Rituximab Trial Fund of £17,000 - Let's Do It!
http://ldifme.org/
Msg from IiME: 'Thank you all for this wonderful support - it sends a message to everyone!'
There is now a Summary of the main points of the trial on the IiME Ritux Trial page:
Quick Overview and Summary of The Main Points of This Trial:
• Invest in ME have initiated a UK rituximab Trial
• Our advisor Professor Jonathan Edwards, Emeritus Professor of Connective Tissue Medicine at University College London (UCL)
• The clinical trial would be performed at University College London
• The UCL service set up when we started treating rheumatoid arthritis, lupus and a range of other conditions has the most extensive experience.
• There is laboratory expertise in B cell immunology under Dr Jo Cambridge.
• UCL also has a new Clinical Trials Research Facility with staff appointed to manage trials of this sort.
• The trial is being set up in collaboration with clinicians with expertise in ME from around London, and in particular Dr Amolak Bansal.
• The UCL proposal will be rigorously evaluated by UCL in their customary comprehensive and very professional manner.
• External peer reviewing will be arranged by UCL and the charity.
• Invest in ME have arranged for Professor Edwards to visit Dr Fluge and Professor Mella in Bergen, Norway to discuss this - enhancing cooperation and research.
• Invest in ME have welcomed support from other charities, organisations, ME support groups and patients in helping us fund this trial.
• We will also accept pledges of financial support pending full peer review of the proposal.
http://www.investinme.org/IIME UK Rituximab Trial Home.htm#Our
http://ldifme.org/
Msg from IiME: 'Thank you all for this wonderful support - it sends a message to everyone!'
There is now a Summary of the main points of the trial on the IiME Ritux Trial page:
Quick Overview and Summary of The Main Points of This Trial:
• Invest in ME have initiated a UK rituximab Trial
• Our advisor Professor Jonathan Edwards, Emeritus Professor of Connective Tissue Medicine at University College London (UCL)
• The clinical trial would be performed at University College London
• The UCL service set up when we started treating rheumatoid arthritis, lupus and a range of other conditions has the most extensive experience.
• There is laboratory expertise in B cell immunology under Dr Jo Cambridge.
• UCL also has a new Clinical Trials Research Facility with staff appointed to manage trials of this sort.
• The trial is being set up in collaboration with clinicians with expertise in ME from around London, and in particular Dr Amolak Bansal.
• The UCL proposal will be rigorously evaluated by UCL in their customary comprehensive and very professional manner.
• External peer reviewing will be arranged by UCL and the charity.
• Invest in ME have arranged for Professor Edwards to visit Dr Fluge and Professor Mella in Bergen, Norway to discuss this - enhancing cooperation and research.
• Invest in ME have welcomed support from other charities, organisations, ME support groups and patients in helping us fund this trial.
• We will also accept pledges of financial support pending full peer review of the proposal.
http://www.investinme.org/IIME UK Rituximab Trial Home.htm#Our